Part II: To CL Or Not To CL: That Ought Not Be The Question
Continuing from Part I, Rishabh Upadhyay explains that making a patented medicine free on paper does not necessarily make it accessible in practice. Through Rajasthan’s procurement...
Search fresh public links, source activity, and ready-to-use post angles for Access To Medicines.
Fresh curated links around Access to Medicines are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Continuing from Part I, Rishabh Upadhyay explains that making a patented medicine free on paper does not necessarily make it accessible in practice. Through Rajasthan’s procurement...
Companies in Africa and India will make generic versions of the pill that could cost as little as $5 per person per year. But access to the drug and other new products in much of L...
The Working Group on Access to Medicines and Treatments said NLEM was last notified in 2022 and contains 384 medicines, while the WHO Model List of Essential Medicines has since be...
For years, Section 92 and 100 levers have occupied a central place in discussions on improving access to patented medicines in India. Yet, despite repeated calls for their use, the...
Brighton Muronzereyi CHIEF WRITER THANKS to the newly-gazetted Medical Services Amendment Act, all Zimbabweans now have access to urgent life-saving care. The... To ac...
Today's guest post comes from Jen Norton, President, Market Access & Value at EVERSANA. Jen examines why fragmented ownership across development, regulatory, pricing, distr...
Many new medicines have reached NHS patients as a result of the government’s reformed pricing arrangements, writes Richard Torbett. Plus a letter from Nick HoileThe suggestion that...
Drug spending continues to grow, but that doesn’t mean that everyone is getting the medicines that they need. A panel at MedCity News’ Bullseye event discussed the evolution of the...
Following in the footsteps of Gilead, Merck has signed voluntary licensing agreements to enable access to its investigational HIV PrEP pill alimatravir ahead of any regulatory subm...
Aurangzeb says pricing decisions must be 'transparent, evidence-based'
Onyebuchi Ezigbo in Abuja The federal government has restated its determination to strengthen access to essential controlled medicines for patients with legitimate medical needs. I...
The Ghana Medical Trust Fund (GMTF) has taken another significant step toward making specialized healthcare more affordable and accessible by engaging key players in Ghana’s pharma...
A medication was recommended to me a week ago. It still has not reached me. I prescribe medications for a living. I know where an order can stall: awaiting a signature, sent but ne...
Pakistan faces a critical shortage of over 100 essential medicines, including life-saving drugs. Delayed price revisions by the Drug Regulatory Authority of Pakistan are disruptin...
Hazel Marimbizain Bulawayo BULAWAYO City Council has partnered the National Pharmaceutical Company (NatPharm) to supply essential medicines to 21 municipal clinics, tackling......
What happens when a patient runs out of approved options, but a promising new treatment is still years from formal approval? Early access programs answer that question, creating a...
Patients waiting for life-changing medicines to be funded say people should not have to fundraise, go into debt, or travel overseas for treatments and therapies that could be admin...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.